Oxford Biomedica is a United Kingdom-based biotechnology company focused on cell and gene therapy. It provides lentiviral vector development and manufacturing services and has also developed proprietary platform technologies for advanced therapies.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!